|
JP2020196709A
|
|
Pharmaceutical containing 6,7-dihydropyrazolo [1,5-a]pyrazinone derivative or salt thereof
|
|
JP2020132638A
|
|
Medicine containing antibody drug conjugate containing hemiasterlin derivative
|
|
JP2020132639A
|
|
Hemiasterlin derivative and medicine containing these antibody drug conjugates
|
|
JP2020050656A
|
|
Pharmaceutical composed of 2,6-di-substituted pyridine derivative
|
|
JP2019203031A
|
|
Irbesartan-containing pharmaceutical composition showing excellent elution, and orally disintegrable tablet
|
|
JP2020193176A
|
|
Novel biaryl derivative and pharmaceutical use thereof
|
|
JP2020183867A
|
|
Crystal screening method and sample preparation plate
|
|
JP2020132531A
|
|
Compounds inhibiting microtubule polymerization and antibody drug conjugates thereof
|
|
JP2020105148A
|
|
Non-aryl heterocyclic substituted aromatic compounds
|
|
JP2019043964A
|
|
Composition with improved light stability
|
|
JP2020019752A
|
|
Chroman derivative
|
|
JP2018168185A
|
|
Irbesartan-containing pharmaceutical composition and orally disintegrable tablet with excellent elution
|
|
JP2019182805A
|
|
Fused pyrazole derivatives having linker site and pharmaceutical applications thereof
|
|
JP2019182784A
|
|
Dihydropyrazolopyrazinone derivatives
|
|
JP2018154620A
|
|
Novel medicine composed of benzimidazole compound
|
|
JP2018044015A
|
|
Composition with improved light stability
|
|
JP2018100270A
|
|
Medicine composed of 1,4-disubstituted imidazole derivative
|
|
JP2018076285A
|
|
Pharmaceuticals containing bicyclic imidazolo derivatives
|
|
JP2020055752A
|
|
Dibenzo diazepine derivative
|
|
JP2017141299A
|
|
Irbesartan-containing pharmaceutical composition showing excellent elution, and orally disintegrable tablet
|
